Skip to main content
. 2017 Jun 28;8(38):63665–63679. doi: 10.18632/oncotarget.18885

Figure 2. AOM/DSS-treated mice showed a significant disturbance of BA profile in serum, liver, ileum, colon, feces and urine compared with normal control mice, analyzed by UFLC-Triple/TOF-MS.

Figure 2

Results are expressed as mean ± S.E.M. of six mice. *P<0.05, **P<0.01 versus normal control, Student's t-test.